
Small bowel bacterial overgrowth is a syndrome caused by an abnormal number of bacteria in the upper part of the small bowel and associated with a complex array of clinical symptoms, i. e., chronic diarrhoea, steatorrhoea, macrocytic anaemia, weight loss, and less commonly, protein-losing enteropathy. The most common underlying factors are small intestinal stagnation or dysmotility, intestinal obstruction, blind or afferent loops, and decreased gastric secretion. The treatment usually consists in the eradication of bacterial overgrowth with repeated courses of antimicrobials, correction of associated nutritional deficiencies and, when possible, correction of the underlying predisposing conditions.
Irritable Bowel Syndrome, Bacteria, Breath Tests, Risk Factors, Intestine, Small, Humans, Drug Therapy, Combination, Blind Loop Syndrome, Anti-Bacterial Agents
Irritable Bowel Syndrome, Bacteria, Breath Tests, Risk Factors, Intestine, Small, Humans, Drug Therapy, Combination, Blind Loop Syndrome, Anti-Bacterial Agents
| citations The total number of citations received by all articles of the researcher of interest. | 14 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
